Dr. Roshan Shrestha, MD

Dr. Shrestha practices at Piedmont Atlanta in Atlanta, Georgia, part of Piedmont Healthcare.

Dr. Shrestha's NPI, 1427191782, was assigned on February 15, 2007. Dr. Shrestha holds Georgia license 056765.

Dr. Shrestha's primary practice is Piedmont Atlanta, at 1968 Peachtree Rd NW, Atlanta, GA 30309 in Fulton County. The practice phone is (404) 605-5000.

Dr. Shrestha's primary practice is Piedmont Atlanta in Atlanta, Georgia, part of Piedmont Healthcare. Dr. Shrestha is also affiliated with St. Luke's Hospital. The medical group on file is Piedmont Physicians Obstetrics and Gynecology of Jasper. Dmand AI also links Dr. Shrestha to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shrestha practices, 3 sites in all. Vendor and product names are available with a free account.

Transplant surgery is Dr. Shrestha's primary specialty in the NPI Registry, under taxonomy code 204F00000X. Dr. Shrestha is licensed in Georgia.

CMS data shows 150 Medicare services from Dr. Shrestha across 5 procedure codes in 2024, for 113 Medicare patients. Medicare paid $16,482 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 113 Medicare patients who saw Dr. Shrestha in 2024. The largest group is 65 to 74, with 69 patients. 75% of them have high blood pressure, and 64% have high cholesterol. Their average risk score is 2.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shrestha's median patient age at 73, with 48% women.

In 2024, Dr. Shrestha wrote 649 Medicare Part D claims for 125 patients. 82% of them were for generic drugs. CMS names the drug for 518 of them, across 17 drugs with 11 or more claims each, at $299,110 in total drug cost. In 2023, CMS named 575 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Shrestha for performance year 2024, reported through an alternative payment model (APM). Dr. Shrestha accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 57 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Shrestha, more than 66% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 921 general payments to Dr. Shrestha from 32 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 53% of the total. Gilead Sciences, Inc. paid the most, $255,151.